BlackRock Fund Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$63M Sell
4,218,356
-42,212
-1% -$748K 0.01% 1529
2016
Q3
$93.4M Sell
4,260,568
-41,148
-1% -$916K 0.02% 1132
2016
Q2
$85.3M Buy
4,301,716
+582,128
+16% +$9.91M 0.02% 1097
2016
Q1
$63.1M Buy
3,719,588
+21,772
+0.6% +$364K 0.01% 1294
2015
Q4
$75.7M Buy
3,697,816
+263,528
+8% +$5.48M 0.02% 1184
2015
Q3
$73.7M Sell
3,434,288
-66,440
-2% -$1.48M 0.02% 1148
2015
Q2
$70M Sell
3,500,728
-5,133,180
-59% -$90.2M 0.02% 1281
2015
Q1
$135M Buy
8,633,908
+110,980
+1% +$1.68M 0.03% 747
2014
Q4
$117M Buy
8,522,928
+1,058,296
+14% +$13M 0.03% 807
2014
Q3
$74.6M Buy
7,464,632
+84,124
+1% +$860K 0.02% 1077
2014
Q2
$73.2M Sell
7,380,508
-309,356
-4% -$2.74M 0.02% 1132
2014
Q1
$79.5M Buy
7,689,864
+279,376
+4% +$2.89M 0.02% 1036
2013
Q4
$65.6M Buy
7,410,488
+73,296
+1% +$580K 0.02% 1189
2013
Q3
$51.8M Buy
7,337,192
+867,824
+13% +$5.5M 0.02% 1315
2013
Q2
$36.3M Buy
+6,469,368
New +$31M 0.01% 1455

Other funds holding DXCM

BlackRock Fund Advisors's DXCM Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its DexCom (DXCM) stake by 0.99% in Q4 2016, selling an estimated $748K and leaving 4,218,356 shares worth $63M. The position accounts for 0.01% of the portfolio, ranked #1529.

BlackRock Fund Advisors first reported a position in DXCM in Q2 2013 and has held it in 15 quarters since. The position peaked at $135M in Q1 2015. 316 funds tracked by Wall St. Rank hold DXCM as of Q4 2016.

  • BlackRock Fund Advisors held 4,218,356 shares of DexCom worth $63M as of Q4 2016.
  • BlackRock Fund Advisors sold 42,212 DexCom shares in Q4 2016, an estimated $748K.
  • DexCom made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1529 holding.
  • BlackRock Fund Advisors first reported a position in DexCom in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's DexCom position peaked at $135M in Q1 2015.
  • 316 funds tracked by Wall St. Rank held DexCom as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.